Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
85.65 EUR | +2.94% | +5.94% | -3.50% |
01/05 | European Equities Traded in the US as American Depositary Receipts Trend Modestly Lower in Wednesday Trading | MT |
25/04 | Sector Update: Health Care Stocks Drop in Afternoon Trading | MT |
Sales 2024 * | 2.79B 2.99B 249B | Sales 2025 * | 2.72B 2.92B 243B | Capitalization | 20.78B 22.3B 1,859B |
---|---|---|---|---|---|
Net income 2024 * | -562M -603M -50.27B | Net income 2025 * | -529M -568M -47.32B | EV / Sales 2024 * | 2.42 x |
Net cash position 2024 * | 14.03B 15.06B 1,255B | Net cash position 2025 * | 13.43B 14.41B 1,201B | EV / Sales 2025 * | 2.7 x |
P/E ratio 2024 * |
-36.8
x | P/E ratio 2025 * |
-36.5
x | Employees | 6,133 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.48% |
Latest transcript on BioNTech SE
1 day | +2.94% | ||
Current month | -3.50% | ||
Current year | -3.50% |
Managers | Title | Age | Since |
---|---|---|---|
Ugur Sahin
CEO | Chief Executive Officer | 58 | 02/08/02 |
Özlem Türeci
FOU | Founder | 57 | 02/08/02 |
Jens Holstein
DFI | Director of Finance/CFO | 60 | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rudolf Staudigl
BRD | Director/Board Member | 69 | 01/22/01 |
Director/Board Member | 67 | 02/08/02 | |
Helmut Jeggle
CHM | Chairman | 53 | 02/08/02 |
Date | Price | Change | Volume |
---|---|---|---|
02/24/02 | 85.65 | +2.94% | 930 |
30/24/30 | 83.2 | +0.79% | 128 |
29/24/29 | 82.55 | +0.49% | 1,562 |
26/24/26 | 82.15 | +1.61% | 2,807 |
25/24/25 | 80.85 | -1.52% | 278 |
Delayed Quote Börse Stuttgart, May 02, 2024 at 10:19 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.65% | 103B | |
+6.75% | 101B | |
+5.71% | 23.07B | |
-9.70% | 18.05B | |
-39.98% | 17.18B | |
-10.17% | 16.94B | |
+6.12% | 14.07B | |
+35.47% | 12.35B | |
+307.09% | 8.35B |
- Stock Market
- Equities
- BNTX Stock
- 22UA Stock